Congenital heart defects are a major cause of mortality after birth, affecting up to 1% of newborns. The vast majority of cases could be detected during fetal screening ultrasound exams. However, this exam is technically challenging and in practice, 50% of cases are missed, thus limiting palliation options for the babies.
BrightHeart is a start-up co-founded by two pediatric cardiologists, experts in fetal cardiac ultrasounds. We are developing an AI-based platform to provide real-time guidance to fetal medicine healthcare professionals during prenatal ultrasound screening exams and support them with the detection of congenital defects. Our goal is to make expert-level prenatal screening diagnosis accessible to all, and inform decisions for pregnancy, delivery and therapeutic management.
- Intelligence artificielle / Machine Learning, Logiciels, Santé
- Paris
- < 15 salariés
